US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) today announced a strategic in-licensing agreement with Chinas Hansoh Pharmaceuticals (03692: HK) for exclusive clinical development and commercial rights outside of the Chinese Mainland, Hong Kong and Macau for a dual GLP-1/GIP receptor agonist currently in Phase III testing
Sustainable, long-term weight loss involves a combination of healthy lifestyle choices, including proper nutrition, physical activity and behavioral changes
These insights may help provide context for baseline response expectations and can support conversations with your provider about dosing strategy and whether combination formulations might be beneficial
Injection site reactions Because Zepbound is given as an injection (vial or Zepbound pen), you may notice redness, itchiness, or a painful sensation around the site, which can last for a few hours but may linger for a couple days in some instances, according to Sowa
Tirzepatide vs Semaglutide: A Comprehensive Comparison for Providers Weight loss medications have undergone a sea change in the past several years
